Long-eradicated diphtheria reappears in Venezuela;

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
Long-eradicated diphtheria reappears in Venezuela; government blames the CIA

Caracas, Venezuela – Diphtheria, an extremely contagious disease that has been mostly eradicated worldwide through vaccination, has reappeared in Venezuela.


So far it has killed four children.

More than 20 cases have been reported in just one month, including those four fatalities in the southern state of Bolivar.

In the crisis-stricken South American nation, many of the children don't have access to the DPT vaccine that prevents the centuries-old disease. Caused by the Corynebacterium diphtheriae bacterium, the disease becomes serious if the bacterial toxin enters the bloodstream and spreads through the respiratory tract. It leads to heart failure and neurological illnesses.

Even with treatment, death occurs in between 5 and 10 percent of those affected.

This week the sense of urgency went up a few notches when a possible case of diphtheria was reported in Caracas’ Military Hospital, considered the country’s best.

Uncertainty has become commonplace in Venezuelan epidemiology.

The reappearance of diphtheria, a disease not seen here in more than 20 years, is the worst symptom yet of the country’s broken health system.

Venezuela used to be Latin America's richest country, but it is now falling apart as a plunge in the price of oil caps off years of economic mismanagement. Local production of almost everything has stalled, and there is little money to import medicine.

Fearing government retaliation, doctors from Bolivar’s Hospital of Guaiparo Raul Leoni opted to do not reveal their identities when on Sept. 21 they reported they had four diphtheria cases, which soon turned into 23.

In the following days, two other states, Sucre and Nueva Esparta, reported a total of four cases to the Venezuelan Society of Infectious Diseases. All four patients have ties with people who had recently visited Bolivar.

When last week the Ministry of Health finally made the announcement acknowledging the resurgence of diphtheria, Diosdado Cabello, a prominent Chavista, said Venezuela is the target of a "germ warfare orchestrated by the CIA labs."

A few days earlier, Marisol Escalona, Coordinator of the government's Expanded Program on Immunization, came out with an odd warning to the medical community: "You cannot report anything (about diphtheria) because it goes against the [Bolivarian] revolution."

According to opposition lawmaker José Manuel Olivares, members of the Intelligence Agency Sebin are “chasing” doctors in Bolivar to try to keep them from speak out about the outbreak.

Olivares said he has information of at least 20 diphtheria-related deaths since April.

The shortage of antitoxins and antibiotics across the country has the potential to turn this outbreak into a national or perhaps regional crisis.

The minimum dosage of antitoxin recommended to treat diphtheria is between 20,000 and 40,000 units when symptoms are only two days old, and between 80,000 and 100,000 if the disease is present for more than three days and the patient's neck is already swollen.

In Bolivar, doctors have to work around a limited supply of 10,000-unit doses — and most of them expired in 2009.

"Venezuela is not prepared to deal with a diphtheria outbreak because we don’t meet the immunization standard recommended by the World Health Organization, because we cannot provide medication in a timely manner and because of flaws in the information flow to the community," said Huniades Urbina, president of the Venezuelan Society of Pediatrics, in a video conference at the Central University of Venezuela.

In addition, the Epidemiological Bulletin has not been published since of November 2014.

Dr. Julio Castro, from the Institute of Tropical Medicine, agrees with Urbina in that containing the outbreak requires a wide vaccination effort.

"For over 20 years we had not witnessed cases of diphtheria disease in Venezuela for a simple reason: it can be prevented by the DPT vaccine (diphtheria, pertussis and tetanus),” he said. “It is possible that the government did not vaccinate the number of people necessary to create the epidemiological barrier."

According to information collected by the Health Ministry but not released to the public (Fox News Latino accessed it through the Venezuelan Society of Public Health), between January and July of 2016 Penta3 vaccination (including diphtheria) covered barely 42 percent of babies in the state of Bolivar.

The first and second booster shot was fulfilled only in 15 percent of the children, the report said.

Jose Felix Oletta, a former health minister and member of the Society, said it was puzzling that the Pan American Health Organization has not yet issued an epidemiological alert on the diphtheria outbreak in Venezuela.

The Society has issued four warnings so far this year.

"It is clear that the strategy adopted by the national health authorities began with attempting to hide the outbreak of diphtheria and now has been replaced with minimizing the magnitude of the epidemic,” the Society of Public Health said.

Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

RealNex Navigator Upgrades Unveil Vast CRE Capabilities

Updated Category News Views 1

The Dawn of a New Navigator for CRE RealNex is unleashing a storm of enhancements to its Navigator platform, shaking up the commercial real estate (CRE) scene. Their latest upgrades are setting a new precedent for how brokers use technology to sharpen their game, handle transactions, and strategize in a market that never sleeps. Diving Deep into the Latest Upgrades First...

Continue Reading
Merit Advisors Shines as Top Energy Workplace

Updated Category News Views 1

Well, here's something to chew on—Merit Advisors just grabbed the top spot on Hart Energy's first-ever Best Places to Work in Energy list. If you haven't heard of them, Merit's the heavyweight champ in specialty tax for the energy sector. This isn't just a shiny trophy on the shelf; it's a nod to the kind of culture that's making waves in an industry that's no stranger...

Continue Reading
Woodpack Global Unveils Crate Design System: A New Era Begins

Updated Category News Views 2

Innovating the Wooden Crate Landscape An old industry got a much-needed facelift today, folks. Woodpack Global has rolled out Crate Design System™ (CDS)—a snazzy new tool that's shaking up the wooden crate design landscape. It blows the dust off outdated design methods that have been collecting cobwebs since the '60s. That's right, we’re talking about a significant...

Continue Reading
Cap Juluca: Caribbean Luxury Redefined on Maundays Bay

Updated Category News Views 2

The Tranquil Call of Maundays Bay Find me dipping my toes in the sands of Maundays Bay come October 10, 2026, and you'll understand why this slice of Anguilla stakes its claim to being the best beach on the globe. Cap Juluca, that crown jewel of Caribbean luxury, swings open its doors once more, promising indulgence framed by turquoise waters and the soft whisper of white...

Continue Reading
Shareholder Rights in Focus: Examining Key Buyouts

Updated Category News Views 4

Shareholder Concerns Rise Amid Corporate Buyouts The stakes are high for the shareholders of Distribution Solutions Group, Eagle Financial Services, Safety Insurance Group, and Utz Brands as their companies face potential buyouts. Let's chew over what's on the table: the sweet deals insiders might score and the legal maneuvers in play. Halper Sadeh LLC, a heavy-hitting...

Continue Reading
AbbVie's Bold Leap in Menstrual Migraine Treatment

Updated Category News Views 0

AbbVie's Game-Changing Atogepant Study When it comes to pushing boundaries in the pharmaceutical world, there's no sitting on the fence. AbbVie's Phase 3 LUNA study results are painting a bright picture for women who suffer from the relentless grip of menstrual migraines. In a world where not a single treatment option has been approved specifically for this condition,...

Continue Reading
Cove Capital Secures $9.96M for Debt-Free Logistics DST

Updated Category News Views 4

Unpacking Cove Capital's Latest Victory Cove Capital Investments has pulled off another coup, raising a hefty $9,964,510 for its Cove Essential Net Lease Industrial 108 DST. It's a Regulation D, Rule 506(c) offering, now fully subscribed, spotlighting a debt-free investment ethos and a rock-solid logistics site in Anchorage, Alaska. Strategic Facility Anchoring Investment...

Continue Reading
RTI's $14M Boost: A Game-Changer for Tech Innovators

Updated Category News Views 0

Breaking Ground in Tech Deployment The march toward commercializing new tech can be a nightmare. Ask any innovator trying to leap from lab genius to market ready, and they'll tell you the pathway is paved with hurdles—especially in the rough-and-tumble world of energy and industrial tech. RTI International's latest $14 million move? That's a massive step in leveling the...

Continue Reading
Navigating Land Access: The Hidden Roadblock in Mining

Updated Category News Views 0

Mining's Often Overlooked Obstacle: Land Access In the world of mining, the shallow thrills of striking gold are often overshadowed by the frustrating slog of securing land access. You can have your permits lined up, your finances sorted, and drills humming along, but if you haven’t sweet-talked the folks farming above your visible vein of riches, you could be staring...

Continue Reading
Global Communication Works Opens SignlLabs™ AI Licensing

Updated Category News Views 45

AI Signaling Moves Beyond GCW's Own Clients Remember when we first looked at GCW's SignlLabs and the idea of helping brands show up inside ChatGPT, Gemini, Claude, Copilot and Perplexity? Well, Global Communication Works is taking the next step. Instead of keeping its AI Signaling playbook inside the agency walls, GCW is now opening SignlLabs up for licensing

Continue Reading
ection End -->

Top 5 Most Recently Viewed Articles

Revolutionizing Views: Space Needle's New Otis Elevators

Updated Category News Views 169

Space Needle Unveils Modern Otis Double-Deck Elevators In a significant upgrade to enhance visitor experiences, the Space Needle has launched its first Otis double-deck glass elevator. This innovative lift is part of a larger project to modernize three elevators at the iconic structure, providing a unique ride with stunning panoramic views. A First Look at the Innovative...

Continue Reading
Key Insights from the Upcoming Press Conference on Assault Case

Updated Category News Views 199

Important Press Conference on Recent Assault Case Attorneys from Matheson & Associates, PLLC are set to hold an impactful press conference aimed at shedding light on a serious incident involving truck drivers engaged in Hurricane Helene cleanup efforts. This incident has raised significant concerns about safety and racial tensions. Understanding the Incident On an...

Continue Reading
Couche-Tard Clarifies Intentions Amid Seven & i Interest

Updated Category News Views 255

Alimentation Couche-Tard Addresses Acquisition Negotiations In recent discussions reported by Japanese media, Alimentation Couche-Tard has made it clear that they are not pursuing a hostile takeover of Seven & i Holdings. Chairman Alain Bouchard emphasized that their strategy focuses on securing a collaborative acquisition approach, rather than a forced or antagonistic...

Continue Reading
Legend Biotech Maintains Strong Outlook Despite Sales Fluctuations

Updated Category News Views 97

Overview of Legend Biotech's Market Performance Legend Biotech Corp. (NASDAQ: LEGN) has been the focus of investor attention lately, with analysts maintaining a Buy rating and a price target of $91. This confidence stems from recent sales data for CARVYKTI, a treatment for multiple myeloma, which saw impressive performance in its latest quarter. CARVYKTI Sales Surpass...

Continue Reading
Transforming Alzheimer's Diagnostics: New Guidelines Unveiled

Updated Category News Views 111

New Era in Alzheimer's Disease Diagnosis In a significant advancement for the diagnosis of Alzheimer’s disease and related cognitive impairments, a comprehensive set of clinical practice guidelines has been introduced, marking a pivotal moment for both primary and specialty care. This newly established guideline serves as a beacon for healthcare providers, ensuring they...

Continue Reading